Bradley A Connor MD AGA-F, FRCPS (Glas)
International Health, Travel & Tropical, Microbiology
Clinical Professor of Medicine, Weill Cornell Medical College.
Join to View Full Profile
110 East 55th Street, 16th FloorNew York, NY 10022
Phone+1 212-988-2800
Fax+1 212-734-4200
Dr. Connor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a Board Certified Gastroenterologist with clinical and research interests in gastrointestinal infectious disease, tropical medicine and parasitology. I am also a Fellow of the Infectious Disease Society of America (IDSA) as a result of my clinical and research contributions to infectious and post-infectious chronic gastrointestinal syndromes post travel and novel enteric pathogens. I am the Medical Director of the New York Center for Travel and Tropical Medicine, Past President of the International Society of Travel Medicine (ISTM), and New York City site director for GeoSentinel, the emerging infectious disease network of the Centers for Disease Control and Prevention (CDC).
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 1982 - 1984
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1978 - 1981
University of Texas Southwestern Medical SchoolClass of 1978
Certifications & Licensure
TX State Medical License 1978 - 2027
CA State Medical License 1981 - 2026
NY State Medical License 1982 - 2026
NJ State Medical License 1984 - 1991
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification athenaClinicals, athenahealth, Inc., 2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification athenaClinicals, athenahealth, Inc., 2014, 2016-2017
- Excellence in Surveillance and Health Monitoring, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC) Centers for Disease Control and Prevention (CDC), 2010
Clinical Trials
- Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO) Start of enrollment: 2020 Jun 30
- HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial Start of enrollment: 2020 Apr 24
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsEfficacy of bismuth subsalicylate on the prevention of travellers' diarrhoea, 2018-2023.Kristina M Angelo, Zainab Salah, Marina Rogova, Ian D Plumb, Allison T Walker
Journal of Travel Medicine. 2025-10-01 - A randomized open label pilot study evaluating the efficacy of two dosing regimens of rifamycin SV MMX in the treatment of small intestinal bacterial overgrowth.Bradley A Connor, Marina Rogova, Jefferson Garcia, Morgan Gardner, Charandeep Waraich
BMC Gastroenterology. 2025-04-03 - 17 citationsEpidemiology of travel-associated dengue from 2007 to 2022: A GeoSentinel analysis.Alexandre Duvignaud, Rhett J Stoney, Kristina M Angelo, Lin H Chen, Paolo Cattaneo
Journal of Travel Medicine. 2024-10-19
Press Mentions
Hydroxychloroquine Is Not Dead YetJune 7th, 2020
Golf Industry Collaborates to Develop Responsible ‘Back2Golf’ Guidelines and Operations PlaybookMay 5th, 2020
Professional Memberships
- Fellow
- Fellow
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
